| Mathew D Hauser, OD | |
|
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
| (888) 988-2800 | |
| Not Available |
| Full Name | Mathew D Hauser |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 441 N Lakeview Ave, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568521284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT8486TPA (California) | Primary |
| Provider Name | Southern California Permanente Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients with peripheral vascular disease with the addition of two longer stents to its SUPERA product line.
In what is being hailed as a significant advance in the treatment of children with sickle cell anemia, a drug commonly used to treat adults has been shown to be safe and effective in children.
When a large group of children with aggressive behavior experienced devastating tornadoes, many of those with higher anxiety showed greater resilience, according to a study published online in the Journal of Clinical Child & Adolescent Psychology, published by the Society of Clinical Child and Adolescent Psychology.
The Wall Street Journal reports that state legislatures are grappling "with deficits totalling $127 billion over the next two fiscal years, according to the National Association of State Budget Officers. ... Of immediate concern to states is the hit they will take if Congress doesn't approve an additional $24 billion to help defray the cost of Medicaid, the federal-state insurance program for the poor. Cost concerns prompted the House to jettison the Medicaid funding this month, and the Senate also is considering stripping out the provision."
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mathew D Hauser, OD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Mathew D Hauser, OD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients with peripheral vascular disease with the addition of two longer stents to its SUPERA product line.
In what is being hailed as a significant advance in the treatment of children with sickle cell anemia, a drug commonly used to treat adults has been shown to be safe and effective in children.
When a large group of children with aggressive behavior experienced devastating tornadoes, many of those with higher anxiety showed greater resilience, according to a study published online in the Journal of Clinical Child & Adolescent Psychology, published by the Society of Clinical Child and Adolescent Psychology.
The Wall Street Journal reports that state legislatures are grappling "with deficits totalling $127 billion over the next two fiscal years, according to the National Association of State Budget Officers. ... Of immediate concern to states is the hit they will take if Congress doesn't approve an additional $24 billion to help defray the cost of Medicaid, the federal-state insurance program for the poor. Cost concerns prompted the House to jettison the Medicaid funding this month, and the Senate also is considering stripping out the provision."
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 5 days ago
Tina Do Optometry, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-956-2785 | |
Dr. Derek Kwon Optometry, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 731 N Euclid St, Anaheim, CA 92801 Phone: 714-533-8240 | |
Krupa J Patel, OD Optometrist Medicare: Medicare Enrolled Practice Location: 5460 E La Palma Ave, Anaheim, CA 92807 Phone: 714-463-7569 | |
Dr. Garrett Scott Wada, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 936 S Brookhurst St, Anaheim, CA 92804 Phone: 714-533-2525 Fax: 714-242-9564 | |
Ely R Almaleh, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Steven Hoffman, Optometrist Medicare: Medicare Enrolled Practice Location: 5460 E La Palma Ave, Anaheim, CA 92807 Phone: 714-463-7500 Fax: 714-992-7850 | |
Ms. Teresa Xuan Do, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 500 S Euclid St Ste D, Anaheim, CA 92802 Phone: 714-635-1100 Fax: 714-635-1155 |